Michael Gladstone - 26 Oct 2022 Form 4 Insider Report for Third Harmonic Bio, Inc. (THRD)

Role
Director
Signature
/s/ Ommer Chohan, Attorney-in-Fact
Issuer symbol
THRD
Transactions as of
26 Oct 2022
Net transactions value
$0
Form type
4
Filing time
27 Oct 2022, 16:49:19 UTC
Previous filing
14 Sep 2022
Next filing
08 Mar 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction THRD Stock Option (right to buy) Award $0 +13,667 $0.000000 13,667 26 Oct 2022 Common Stock 13,667 $17.83 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests over a 8-month period: 1/8th on October 26, 2022, after which 1/8th of the total shares vest monthly, subject to continued service through each vesting date.
F2 The Reporting Person is a member of Atlas Venture Life Science Advisors, LLC ("Atlas") and is obligated to transfer the economic benefit, if any, received upon the sale of the shares issuable upon exercise of the option to Atlas. As such, the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any.